Remove category in-the-lab
article thumbnail

STAT+: The FDA’s diagnostics chief, who led through Covid, has retired

STAT

The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization.   It was a hectic time.

363
363
article thumbnail

Merck announces 3rd edition of Merck Young Scientist Award 2023

Express Pharma

Dhananjay Singh, Head of Science and Lab Solutions, Merck Life Science said, “ This year, we have chosen to focus on sustainability apart from the disciplines of Chemistry and Biology since we believe as an organisation that sustainability is a key pillar of scientific research. research experience and reside in India.

91
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Award Shortlists 2022

Pharmaceutical Technology

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. AstraZeneca/Daiichi Sankyo Nokia Bell Labs andEquideum Health Oak Hill Bio. The category also includes projects that contribute to the environment such as tree planting schemes and river cleaning.

52
article thumbnail

Verix boosts life science AI capabilities with start-up.ai acquisition

Pharmaceutical Technology

The company will be merged with Verix’s AI lab, and start-up.ai The company also uses anonymised drug prescription data from healthcare professionals (HCPs) and multiple data sets such as lab data, digital marketing information and demographics to help pharma firms optimise the processes related to their business. start-up.ai

52
article thumbnail

Median Tech debuts AI-focused unit for cancer trial support

pharmaphorum

The new Imaging Lab business will deploy AI, data mining, and radiomics technologies to medical imaging data generated in cancer trials, said Median. billion, it said, compared to $1 billion for new medicines in other therapeutic categories, citing data from a 2020 analysis published in the Journal of the American Medical Association.

98
article thumbnail

Excellence Awards 2022 – Winners Announced!

Pharmaceutical Technology

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. AstraZeneca/Daiichi Sankyo Nokia Bell Labs andEquideum Health Oak Hill Bio.

article thumbnail

BMS embraces AI drug discovery with $1.2bn Exscientia alliance

pharmaphorum

BMS wants to harness Exscientia’s tech to discover small-molecule drugs across a range of therapeutic categories – including immunology and oncology – and is promising another $125 million in near- and mid-term milestones to the project if all goes well. All told, the value of the deal could be as much as $1.2

68